US Edition
Health Canada Authorizes Clinical Trial for Cellulose-Based Dermal Filler
Summary by Plastic Surgery Practice
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Health Canada Authorizes Clinical Trial for Cellulose-Based Dermal Filler
The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation. Spiderwort Biotechnologies Inc has received Investigational Testing Authorization from Health Canada to initiate a human clinical trial of its investigational dermal filler, CelluJuve. The company is developing the product as a cellulose-based alternative for tissue augmentation and fac…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
